Uncategorized


Updated US Guideline on Pharmacologic Prevention of Migraine in Adults

The US updated evidence-based recommendations provide clinicians with comprehensive guidance on when to initiate pharmacologic migraine prevention, how to select an appropriate preventive medication, and how to monitor treatment effectiveness, adverse effects, and medication discontinuation in adults. Developed by a multidisciplinary panel using a systematic review of studies published through […]


Multiday Heart Rate Rhythms Common in Young Adults

In a US retrospective observational cohort study of 623 young adults, significant infradian (multiday) heart rate rhythms were detected in 70% of participants, with 36% showing two or more distinct rhythms. Using up to four years of wearable and questionnaire data from the University of Notre Dame’s NetHealth project, researchers […]


Viral Reactivation During Acute COVID-19 and Long COVID

In a US longitudinal multi-omic study of 1,154 hospitalized patients with COVID-19 from the IMPACC cohort, significant reactivation of Herpesviridae and Anelloviridae was common during acute COVID-19, with virus-specific temporal patterns and associations with disease severity, host immune responses, and clinical outcomes. Chronic viral infections are ubiquitous in humans, and […]


Accelerated Biological Aging Linked to Higher Cancer Risk

Accelerated biological aging was associated with a higher risk of early-onset solid cancers in young adults, particularly lung, gastrointestinal, and uterine cancers, suggesting that biological aging may help explain the rising incidence of cancer in recent generations. In a study of 154,169 young adults from the UK Biobank, systemic biological […]


Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that anti-obesity medications vary substantially in both effectiveness and safety, with greater weight loss generally accompanied by higher rates of adverse events and treatment discontinuation. At one year, tirzepatide and cagrilintide-semaglutide (CagriSema) produced the greatest confirmed […]